Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 2 de 2
Filtrar
Más filtros










Base de datos
Intervalo de año de publicación
1.
Niger J Clin Pract ; 22(1): 92-100, 2019 Jan.
Artículo en Inglés | MEDLINE | ID: mdl-30666026

RESUMEN

OBJECTIVES: A prospective case-control study was carried out to assess the value of elastosonography in identifying endometrial pathology in women using Tamoxifen (TAM) for breast cancer. MATERIALS AND METHODS: In total, 66 women using TAM for breast cancer were enrolled for the study with 61 premenopausal and 61 postmenopausal healthy controls. Ultrasonographic findings (strain ratio, endometrial thickness) were evaluated in regard to the duration of TAM usage, histopathological findings, and menopausal status. RESULTS: Patients with endometrial cancer (EC) and cystic endometrial hyperplasia (CEH) were found to have longer duration of TAM usage, increased endometrial thickness, and higher strain ratios compared with controls. A significant positive correlation was found between duration of TAM usage, endometrial thickness, and the strain ratios. Endometrial thickness and the strain ratios were significant predictors for groups under risk. Cutoff values for endometrial thickness, strain ratios, and duration of TAM usage were 12.55 mm, 2.46, and 18 months in premenopausal group and 7.75 mm, 7.70, and 32 months in postmenopausal group to predict risky population, respectively. CONCLUSION: Endometrial tissue strain ratio was found to be significantly increased in cases with endometrial pathologies. Addition of elastosonography modality to B-mode may improve the diagnostic accuracy during the follow-up of women using TAM for breast cancer.


Asunto(s)
Antineoplásicos Hormonales/efectos adversos , Neoplasias de la Mama/tratamiento farmacológico , Diagnóstico por Imagen de Elasticidad/métodos , Hiperplasia Endometrial/diagnóstico por imagen , Neoplasias Endometriales/diagnóstico por imagen , Endometrio/diagnóstico por imagen , Tamoxifeno/efectos adversos , Ultrasonografía/métodos , Adulto , Anciano , Anciano de 80 o más Años , Antineoplásicos Hormonales/uso terapéutico , Neoplasias de la Mama/patología , Estudios de Casos y Controles , Hiperplasia Endometrial/inducido químicamente , Neoplasias Endometriales/inducido químicamente , Endometrio/efectos de los fármacos , Femenino , Humanos , Persona de Mediana Edad , Posmenopausia , Premenopausia , Estudios Prospectivos , Tamoxifeno/uso terapéutico
2.
Allergy ; 69(2): 265-8, 2014 Feb.
Artículo en Inglés | MEDLINE | ID: mdl-24251444

RESUMEN

A relationship between serum basal tryptase (sBT) levels, anaphylactic reactions, and clonal mast cell diseases was shown recently in adults with venom allergy, but the relationship between sBT levels and IgE-mediated food allergy and anaphylaxis is not known. In this study, children with food allergy (FA; n = 167) were analyzed in two groups according to the presence (FA+/A+; n = 79) or absence of anaphylaxis (FA+/A-; n = 88) and were compared with a control group (n = 113). Median sBT values in FA+/A+, FA+/A-, and control groups were 4.0 ng/ml (2.8-5.8), 3.6 (2.3-4.5), and 3.3 (2.4-4.4), respectively (P = 0.022). sBT measurements higher than the cutoff values of 5.7 and 14.5 were associated with 50% and 90% predicted probabilities, respectively, of moderate to severe anaphylaxis. Children with tree nuts/peanut allergies had significantly higher levels of sBT than children with milk and egg allergy (P = 0.022). Results suggest that sBT levels may predict moderate to severe anaphylaxis in children with food allergy, which may follow a particular pattern according to the food allergy phenotype.


Asunto(s)
Anafilaxia/sangre , Anafilaxia/enzimología , Hipersensibilidad a los Alimentos/sangre , Hipersensibilidad a los Alimentos/enzimología , Triptasas/sangre , Anafilaxia/etiología , Biomarcadores/sangre , Preescolar , Femenino , Hipersensibilidad a los Alimentos/complicaciones , Humanos , Lactante , Masculino , Factores de Riesgo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA
...